This is a limited company view. Sign up for a Free Trial to see everything.

F2G discovers and develops novel drugs for the treatment of life-threatening fungal diseases.

B2B
Biotechnology
Healthcare
Pharmaceuticals

Overview

Location

Manchester

Founded

Employees

21

Stage

Late

Total funding

$150M

Last funding

4 months ago

Acquisitions

0

Growth score

33

Mindshare score

27

Scoring

Employee Growth

Use F2G's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use F2G's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Key People

CMC Project Manager
Clinical Project Manager
Gerente Comercial
Head of Chemistry
Vice President, Clinical Development
Head of Biochemistry and Molecular Biology
Chief Scientific and Development Officer
Financial Controller
Head of Microbiology
Research Scientist

Similar Companies

Tioma Therapeutics

Tioma Therapeutics is a biotechnology company focused on novel therapies for disorders driven by CD47 signaling pathways. Vasculox is developing a portfolio of anti-CD47 therapeutic antibodies for the treatment of cancer and pulmonary hypertension, the prevention of certain complications of solid organ transplantation, and other important medical applications.
Series A|3 employees

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes